Head of Investor Relations

Lycia Therapeutics•South San Francisco, CA
•$225,000 - $375,000

About The Position

Lycia Therapeutics is hiring a Head of Investor Relations to build its investor relations function following the company’s initial public offering. The title will reflect the experience of the person hired. Reporting to the Chief Financial Officer and working closely with the Chief Executive Officer and executive team, this leader will manage relationships with investors, sell-side analysts, and banking partners, and shape how Lycia’s science, clinical progress, and financial position are communicated to the market. This is a hands-on opportunity to build a public-company investor relations program from the ground up. The role may be hybrid at Lycia’s South San Francisco headquarters or remote, with periodic office attendance for key meetings and milestones. Regular travel to investor meetings and conferences is required. The position offers a base salary of $225,000 to $375,000, determined by experience, skills, and level, and is eligible for an annual performance bonus, equity, and Lycia’s benefits program.

Requirements

  • 10 or more years of experience in biotechnology investor relations, capital markets, equity research, investment banking, or an IR advisory firm.
  • Direct experience leading investor relations at a public company or advising public-company management teams.
  • Track record of supporting clinical readouts, financings, and other market-moving events.
  • Established relationships with healthcare-focused institutional investors, sell-side analysts, and banks.
  • Working knowledge of SEC disclosure requirements, Regulation FD, and public-company reporting processes.
  • Scientific fluency sufficient to explain a novel therapeutic platform and clinical data credibly to specialist investors.
  • Strong writing skills, judgment, and executive presence.
  • Comfort operating as a hands-on, one-person function and working closely with the management team.
  • Bachelor’s degree required.

Nice To Haves

  • Advanced degree in the life sciences or business.

Responsibilities

  • Build and lead Lycia’s investor relations strategy, annual IR activities, and investor targeting program to develop a high-quality, long-term institutional shareholder base; monitor shareholder composition, trading activity, and investor sentiment.
  • Own the equity story and investor narratives, adapting the investment case and corporate presentation for different audiences while maintaining scientific precision.
  • Lead planning for clinical data releases, including disclosure timing, press releases and presentation materials, key opinion leader participation, and post-release investor follow-up, in coordination with clinical, regulatory, and legal teams.
  • Plan and execute investor and disease-specific conferences, non-deal roadshows, investor and analyst events, and key opinion leader events; prepare management for these events.
  • Lead communications for quarterly reporting and clinical, regulatory, financing, and corporate milestones, including press releases, key messages, and investor Q&A; partner with Legal and Finance on disclosure controls and review of external materials.
  • Partner with the Chief Business Officer on corporate communications; own investor-facing website content, press releases, and corporate social media, and contribute to broader media, partner, and brand messaging to keep positioning consistent.
  • Build relationships with sell-side analysts, review their models in depth, and lead strategic expansion of analyst coverage beyond current analysts.
  • Lead competitive intelligence and synthesize input from investors, analysts, key opinion leaders, and other market participants to sharpen positioning, test assumptions, and inform program strategy in accordance with Lycia’s scientific and compliance processes.
  • Apply AI and digital tools to literature and competitor synthesis, landscape monitoring, message testing, and investor meeting tracking; proactively bring insights to management.

Benefits

  • Annual performance bonus
  • Equity
  • Lycia’s benefits program
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service